Brian P. Dunphy

Associate vCard


  • Boston College (JD)
  • Boston College (BA)

Bar Admissions

  • Massachusetts

Brian advises health care providers, biotechnology and life sciences companies, clinical laboratories, and pharmaceutical and medical device manufacturers and represents them in health-care litigation, government investigations, and product liability cases. He is also a member of the firm’s Health Care Enforcement Defense Group and is a frequent author on health care fraud and abuse issues. Specifically, Brian:

  • Defends clients against government investigations of alleged violations of the False Claims Act (FCA) and the Anti-Kickback Statute (AKS)
  • Litigates whistleblower complaints brought under the FCA and its state analogues in federal court Defends pharmaceutical and biotech companies in national product liability cases

  • Represents clients in complex business disputes, including disputes arising from collaboration, distribution, and supplier agreements in the biotechnology and life sciences industry

  • Advises clients on health care regulatory issues, including compliance with the federal Physician Payments Sunshine Act (and analogous state laws) as well as the PhRMA and AdvaMed codes of conduct  

  • Trains marketing and sales forces on compliance with these laws and codes

Brian is also committed to pro bono work. Brian advises a non-profit organization dedicated to researching and preventing traumatic brain injuries. He has successfully represented an asylum seeker in removal proceedings and a disabled student seeking a residential educational placement. As a result of his pro bono work, Brian was selected to participate in the Boston Bar Association’s Public Interest Leadership Program.

Before attending law school, Brian was a project manager at Accenture, a management and technology consulting firm. He utilizes his project management skills working with his current clients.

Representative Current and Past Matters

  • Represented a publicly traded biotechnology company and a pharmaceutical company in ongoing multi-jurisdictional product liability disputes involving an FDA-approved pharmaceutical drug
  • Defended a health care client in a government investigation of possible false claims and violations of the AKS resulting from a whistleblower complaint
  • Obtained dismissal of a whistleblower’s state and federal FCA claims against a Pharmacy Benefit Manager in federal court
  • Achieved victory in an arbitration for an international life sciences company initiated by one of the company’s suppliers. After an evidentiary hearing, a panel of arbitrators rejected the supplier’s claims and entered judgment for our client on its counterclaim, including recovery of our client’s attorneys’ fees and costs
  • Conducted an internal investigation of a health care provider and prepared a self-disclosure to the U.S. Department of Health and Human Services, Office of Inspector General (OIG)
  • Successfully opposed the OIG’s proposed exclusions of a physician from federal health care programs

Recognitions & Awards

  • Boston Bar Association Public Interest Leadership Program (2010 – 2011)
  • Massachusetts Super Lawyers: Rising Star (2014 – 2015) 
  • Greater Boston Chamber of Commerce, Boston Future Leaders Program

Professional & Community Involvement

  • Member, Boston Bar Association
  • Member, Massachusetts Bar Association
  • Member, American Bar Association
  • Member, American Health Lawyers Association